Skip to content
Generic

Neonatal hyperinsulinism

Glaser B, Landau H, Permutt M ...see all

Trends in Endocrinology and Metabolism, vol. 10, issue 2 (1999) pp. 55-61

  • 13

    Readers

    Mendeley users who have this article in their library.
  • 35

    Citations

    Citations of this article.
  • 1.3k

    Views

    ScienceDirect users who have downloaded this article.
Sign in to save reference

Abstract

Hypoglycemia as a result of hyperinsulinism in the newborn (HI) is a clinically heterogeneous entity that presents a diagnostic and therapeutic challenge to the treating physician. Recent discoveries have shown that mutations in four different β-cell genes cause HI. However, for many HI patients, the molecular etiology is unknown, and other genes might be involved. The study of the molecular biology of HI has led to a better understanding of pancreatic β-cell physiology. In the future, this might result in the development of novel drugs for the treatment of both hyperinsulinism and non-insulin-dependent diabetes.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Benjamin Glaser

  • Heddy Landau

  • M. Alan Permutt

Cite this document

Choose a citation style from the tabs below